Emergent Biosolutions (EBS)

• Market cap: $685M
• 1 day: 36.6%
• 5 days: 30.36%
• 1 month: 45.58%
• 3 months: 111.53%
• 6 months: 140.45%
• Year to date: 25.02%
• 1 year: 33.75%
• 5 years: -85.73%
• 10 years: -60.06%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.

Employees: 900